Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $66.6 million versus the consensus estimate of $66.57 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
